Plasmalogens enhance the activity of α-secretase, leading to the non-amyloidogenic cleavage of amyloid precursor protein (APP) into non-amyloidogenic peptides, thereby reducing the formation of amyloid plaques, a hallmark of AD neuropathology [66]. Here, APP is linked to Alzheimer disease.